In this video, IMF Chief Medical Officer Joseph Mikhael defines and explains the differences between monoclonal antibodies and bispecific antibodies. He also describes how CAR T-cell therapy involves a complex process of collecting and manufacturing CAR T-cells, whereas bispecific therapies are drugs that can be taken off the shelf and can act immediately.
_______________
Improving Lives | Finding the Cure

Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of lives of myeloma patients while working toward prevention and a cure through our four founding principles: Research, Education, Support, and Advocacy.

Subscribe to our channel: [ Ссылка ]

Visit our website at: [ Ссылка ]

Find us online:
Facebook: @myeloma | [ Ссылка ]
Twitter: @IMFMyeloma | [ Ссылка ]
Instagram: @imfmyeloma | [ Ссылка ]
LinkedIn: [ Ссылка ]

Support the IMF | Donate Now! [ Ссылка ]
Category
Nonprofits & Activism
License
Standard YouTube License

In most cases, captions are autogenerated by YouTube.

свернуть